Product Information

BUPRENORPHINE 10 MCG/HR PATCH is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $33.7526 per EA under NDC 50742037404. Its NADAC has been published 144 times since Nov 22, 2023.

FDA first approved this application on Sep 23, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE 10 MCG/HR PATCH

Buprenorphine
$33.7526per EA
DEA Schedule CIII

Strength

10 ug/h

NDC

50742037404

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Effective Date

8/19/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Generic (ANDA)

FDA Application

ANDA210272

FDA Approved

9/23/2021

TE Code

AB

On Market Since

11/1/2023

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE 10 MCG/HR PATCH has been published 144 times since Nov 22, 2023, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$33.7526 per EA
All-time high$44.1259 (Dec 13, 2023)
All-time low$25.2344 (Nov 20, 2024)
52-week high$36.0012
52-week low$29.8808
Median price$32.1775
Average price$33.2798
Largest weekly change+30.1% (Aug 21, 2024)
Weeks tracked144
Tracking sinceNov 22, 2023

Price History

1W

+7.8%

1M

+7.8%

3M

+10.4%

6M

+11.9%

1Y

-6.2%

3Y

N/A

5Y

N/A

All

-23.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE 10 MCG/HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 10 MCG/HR PATCH, manufactured by Ingenus Pharmaceuticals LLC, is $33.7526 per EA (NDC 50742037404), effective Aug 19, 2026.

How has the price of BUPRENORPHINE 10 MCG/HR PATCH changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE 10 MCG/HR PATCH has declined 23.5%. It has been tracked across 144 weekly CMS publications since Nov 22, 2023.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 10 MCG/HR PATCH?

Since Nov 22, 2023, the NADAC for BUPRENORPHINE 10 MCG/HR PATCH has ranged from a low of $25.2344 (Nov 20, 2024) to a high of $44.1259 (Dec 13, 2023), with a median of $32.1775 per EA.

Are there cheaper alternatives to BUPRENORPHINE 10 MCG/HR PATCH?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 10 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE 10 MCG/HR PATCH?

BUPRENORPHINE 10 MCG/HR PATCH (NDC 50742037404) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.